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Abstract
TITLE: Posttraumatic Stress as a unique contributor to related health outcomes and
healthcare utilization in adult survivors of childhood cancer
AUTHOR: Emily Kathleen Crochet, M.S.
MAJOR ADVISOR: Vida L Tyc, Ph.D.
Despite its significance in medical populations, research on posttraumatic
stress (PTSS) in this population is limited in existing studies by small sample sizes and
lack of follow-up data. This manuscript provides review of literature on behavioral
health outcomes, which include neurocognitive and psychosocial late effects of
disease/treatment, engagement in health-promoting or risk behaviors, and healthcare
utilization in the childhood cancer survivor population. The current study examined
the impact of PTSS on these domains of functioning, using data from the Childhood
Cancer Survivor Study (CCSS), a multi-institutional sample.
Results indicated 13.7% of survivors in our sample experienced PTSS.
Survivors with PTSS were at significantly greater risk for emotional distress, poor
health-related quality of life, and neurocognitive impairment than survivors
without PTSS. PTSS also variably affected healthcare utilization, defined as
frequency of contact with the healthcare system for medical services. These
findings emphasize the role of PTSS in psychosocial and behavioral health
outcomes in survivors already at increased risk for late effects and highlight the
need to address PTSS in future preventative interventions.
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Background
Posttraumatic Stress Disorder (PTSD)
Posttraumatic Stress Symptoms (PTSS) include a unique manifestation of
distress experienced by those who have been exposed to trauma as defined by a
perceived threat to one’s own life or that of a loved one. This is characterized by a)
intrusive symptoms, such as recurrent, involuntary thoughts of a stressor; b) avoidance
of external cues or reminders of the stressor, and c) hypervigilance, a heightened state
of sensory arousal and behavioral reactivity following exposure to serious injury,
interpersonal violence, death, or perceived threat of death (American Psychiatric
Association, 2013). According to the National Comorbidity Survey (Yehuda, 2001),
the prevalence of PTSD in the general population ranges from 5-6% of men and 1014% in women. Subsequent review of special populations estimates the disorder to be
most prevalent in those exposed to interpersonal violence, with 55% of sexual assault
victims developing the disorder as compared to 7.5% of individuals involved in
vehicular accidents (Yehuda, 2001).
Although less frequently discussed in the literature, a portion of medical
patients also experience posttraumatic stress related to life-threatening illness, with
pediatric cancer survivors yielding prevalence rates from 8-20% (Lee, 2006; Meeske,
Ruccione, Globe & Stuber, 2005; Schwartz & Drotar, 2005; Schwartz, Kazak, Derosa,
Hocking, Hobbie & Ginsberg, 2001; Stuber et al., 2010). Within the Childhood
Cancer Survivor Study (CCSS) cohort, survivors were at four times greater risk of
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developing PTSD when compared to siblings, with symptoms often occurring in
adulthood (Stuber et al., 2010). It should be noted that most survivor studies report
symptom levels of posttraumatic stress symptoms (PTSS), while few have used
measures that allow for categorical diagnoses of PTSD (Meeske et al, 2005). In this
study, PTSS was defined by an adapted form of the DSM-IV PTSD Checklist (PCL
civilian).
While disease and treatment type have not been found to have a significant
impact on the development of PTSS in survivors (Kazak et al., 2010; Stuber et al,
2010), the survivor’s perception of their cancer experience and perceived intensity of
treatment have been found to affect levels of distress (Lee, 2006). Age at cancer
diagnosis has also been identified as a significant predictor of PTSS, with those
diagnosed in adolescence experiencing poorer outcomes than those diagnosed at
younger ages (Kazak et al., 2010; Stuber et al, 2010). This is seen across psychosocial
outcomes, as the longer and more challenging treatment of adolescent cancers can
delay or interrupt important developmental tasks (e,g, autonomy, peer pressure,
interpersonal relationships with peers) and cause psychological distress that persists
well into adulthood (Kazak et al., 2010). Adolescents also possess the awareness and
cognitive maturity to remember and reflect on their cancer experience, and better
understand the implications of their cancer treatment, which may further increase their
distress (Kazak et al., 2010; Stuber et al, 2010). Socio-emotional factors, such as
coping abilities and vulnerability to social exclusion, are also likely factors which
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contribute to negative views of self and perceptions of the event (Schwartz & Drotar,
2005) during this developmental stage.
In general, studies show that psychosocial difficulties and PTSS become
more prevalent over time and often peak in young adulthood (Stuber et al., 2011),
years after cancer treatment has ended. In addition to the tasks expected of any
individual in this developmental phase of life, young adulthood is the time when late
effects typically emerge and serve as a catalyst for recognition of the survivor’s
perceived limitations. As they approach adulthood, survivors are expected to
incorporate formation of identity and self-concept, adaptation to personal autonomy,
social functioning, and higher educational or vocational expectations (Meeske,
Ruccione, Globe & Stuber, 2005; Stuber et al., 2010). Many survivors with PTSS
struggle with these developmental tasks, secondary to the physical and cognitive
impact of their cancer treatment. As a result, some young adult survivors report poor
perceptions of health status, diminished Health Related Quality of Life, low
satisfaction with healthcare, increased adjustment difficulties, psychosocial distress,
and a higher perceived impact of prior illness on educational and vocational
accomplishments (Meeske, Ruccione, Globe & Stuber, 2001; Schwartz & Drotar,
2005; Schwartz et al., 2011; Kazac et al., 2010).

Late Effects
Medical advances in treatment of pediatric cancer have resulted in increasingly
higher survivorship rates. Specifically, between the years of 2004-2010, it was found
3

that more than 80% of patients diagnosed with cancer prior to age 20 achieved 5-year
survival (Howlader, Noone, Krapacho et al [eds], 2011). With survivorship rates
rising, a growing amount of attention has been given to the long- term impact of
treatment, which often increases risk for chronic illness and second malignant
neoplasms (Lee, 2006; Oeffinger, Nathan & Kremer, 2008; Stuber et al., 2010). This
is an important area of research as survivors of pediatric cancer experience a variety of
late-effects, or conditions and outcomes that arise 5 or more years after disease
remission, with some emerging decades after treatment (Lee, 2006; Oeffinger, Nathan
& Kremer, 2008; Stuber et al., 2010). Currently, it is estimated that nearly 50% of
survivors experience moderate to severe late effects which include medical conditions,
such as cardiovascular disease and fertility problems, as well as poor neurocognitive
and psychosocial outcomes (Oeffinger, Nathan & Kremer, 2008). Survivors with
PTSS are reported to be more likely among this group, reporting more moderatesevere late effects than those without PTSS (Meeske, Ruccione, Glove, & Stuber,
2001). Although some late effects can be effectively managed with pharmacological
treatment, it is estimated that 35% of survivors develop disabilities that significantly
impair their quality of life (Brinkman et al., 2013 [b]; Lee, 2006).
Neurocognitive late effects.
Neurocognitive impairment is one of the most common late effects, with
executive functioning deficits occurring in approximately 20-40% of survivors (Ford,
Barnett & Werk, 2014; Krull et al., 2011). The Childhood Cancer Survivor Study
Neurocognitive Questionnaire (CCSS-NCQ) was developed to assess neurocognitive
4

impairment frequently seen in survivors. Abilities assessed include initiating and
completing tasks, emotional reactivity, frustration tolerance, organization of materials
or planning of events, attention, short-term memory, and long-term memory (Kenzik
et al., 2015; Recklitis et al., 2006). Using the CCSS-NCQ, it has been estimated that
survivors of non-central nervous system malignancies are at 50% higher risk of
impairment than healthy siblings, particularly in domains related to task efficiency,
memory, and emotional regulation (Kadan-Lottick et al., 2010; Krull et al., 2015).
Survivors who were diagnosed before 6 years of age, were female, received cranial
radiation, or had hearing problems demonstrated the greatest impairment (KadenLottick et al., 2010). Survivors of central nervous system (CNS) malignancy, who
received high-dose cranial radiation to frontal areas of the brain, were found to
demonstrate significantly greater impairment in the areas of attention, processing
speed, memory, task efficiency, and emotional regulation as compared to those with
non-CNS malignancies, on the same measure (Ellenberg et al., 2009; Krull et al.,
2015). Survivors presenting with symptoms of anxiety and depression were even more
impaired in memory and task efficiency, as well as emotional regulation (KaadenLottick et al.,2010).
Risk for neurocognitive impairment varies based on treatment type with
higher rates of impairment reported in those who have been treated with cranial
radiation, methotrexate, corticosteroids (dexamethasone), high-dose cytarabine,
placement of a ventriculoperitoneal (VP) shunt, or had suffered a cerebrovascular
incident (Ellenberg et al., 2009; Nathan & Kremer, 2008; Oeffinger). Additionally,
5

patients treated with intrathecal methotrexate showed significantly greater impairment
than those treated with systemic methotrexate only (Kaden-Lottick, 2010). Some of
these effects may, in part, result from white matter changes in patients treated with
these neurotoxic regimens (Kaden-Lottick, 2010).
Earlier studies reported significant cognitive deficits among children who
received cranial radiation therapy at 18-24 Gy as prophylaxis against CNS leukemia, as
well as those who received high dose systemic and intrathecal chemotherapies (Brown
et al., 1992; Cousens, Waters & Stevens, 1988; Meadows et al., 1981; Mulhern,
Wasserman, Fairclough & Ochs, 1988; Ochs et al.,1991). Likewise, survivors of CNS
tumors requiring neurosurgery and high dose cranial radiation therapy have been found
to experience global cognitive declines as severe as 20-40 IQ points (Mulhern,
Wasserman, Farclough & Ochs, 1988). Although patients treated with contemporary
approaches are expected to suffer less severe neurocognitive deficits, due to protective
changes in treatment protocol, these individuals will likely experience mild declines that
undermine daily functioning (Oeffinger, Nathan & Kremer, 2008). These underlying
executive deficits, reported across studies, have been shown to adversely affect
emotional, educational, and vocational functioning as well as achievement of adult life
goals among survivors (Ellenberg et al., 2009; Kaden-Lottick et al., 2010).
Chronic stress in childhood and adolescence has been shown to correspond
with both structural and chemical changes in the brain, most often manifested as
emotional dysregulation and impairments in memory (Lupien, McEwen, Gunnary &
Heim, 2009). High levels of PTSS in survivors have also been hypothesized to further
6

exacerbate functional deficits associated with neurocognitive impairment (Meeske,
Ruccione, Globe, & Stuber, 2001). Additionally, chronic PTSS is expected to have an
indirect effect on cognition through higher levels of sleep disturbance and fatigue
(Earle, Neville & Fletcher, 2007; Phillips-Salimi, Lommel & Andrykowski, 2011),
each of which have been reported to lead to impaired task efficiency and memory
among survivors (Clanton et al., 2011). In fact, the degree of neurocognitive
dysfunction associated with PTSS-related health effects has been estimated to be
comparable to the level of neurocognitive impairment resulting from high dose cranial
radiation therapy (Clanton et al., 2011). These findings suggest the importance of
targeting PTSS-related factors to improve functional outcomes among survivors.

Psychosocial late effects.
Survivors often experience psychosocial late effects, which include mental
health disorders as well as conditions such as chronic pain and fatigue (Oeffinger,
Nathan & Kremer, 2008). Prevalence rates for psychosocial late effects differ across
studies, due to variability in the outcome measures employed as well as the way in
which distress or clinical impairment is defined (Brinkman et al.,2013 [b]; Meeske et
al., 2001; Zeltzer, et al., 2009). Research from the CCSS cohort suggests 17% of
cancer survivors experience symptoms of depression or anxiety, being twice as likely
as siblings to report these outcomes (Oeffinger, Nathan & Kremer, 2008 & Zeltzer et
al., 2009). However, this cross-sectional study was limited as it assessed symptoms
experienced by survivors at a single point in time. Several long-term studies of
7

psychological distress in survivors of childhood cancer have suggested that while most
survivors of childhood cancer present with minimal distress (Michel et al., 2010;
Zeltzer et al., 2008), some subsets report significant and variable levels of anxiety,
depression, and somatization (Brinkman et al.,2013 [b]). For example, higher levels of
depression are reported among survivors with CNS malignancies when compared to
siblings and US norms, while greater somatic symptoms have been reported for
survivors of Hodgkins and non-Hodgkins lymphoma (Zebrack et al., 2004; Zeltzer et
al., 2008)). More recent longitudinal examination of distress among survivors at points
in time was consistent with previous cross-sectional reports showing increased distress
among subgroups of survivors (Brinkman et al., 2013 [b]). Specifically, survivors
most at risk for chronic distress were those with worsening physical health and pain
over time, suggesting that survivors with physical health morbidities should be
regularly screened for mental health difficulties (Brinkman et al., 2013 [b]).
The reliance on survivors’ self-report of psychosocial morbidity across most
studies raises questions as to whether the reported rates accurately estimate their
experienced symptoms. Brinkman and colleagues (2013 a) found that 19% of
survivors in the CCSS cohort initiated antidepressant medication over a 10-year
follow-up period; increased use of medication was associated with increased
psychological distress over time. Additionally, survivors were significantly more
likely to utilize antidepressants and other psychoactive medications when compared to
sibling controls (Brinkman et al., 2013 [a]). Whether symptom rates reported across
studies are a low estimate of actual distress secondary to effective pharmacological
8

management of their symptoms or whether medication seeking behavior reflects
elevated distress symptoms that may be underreported remains unclear. Longitudinal
studies that monitor the course of symptoms concurrently with medication utilization
are warranted to better understand the trajectory of psychological distress in survivors
of childhood cancer.
Posttraumatic stress has been demonstrated to exacerbate psychosocial
distress in survivors, with greater impairments seen in survivors with PTSS than those
without. Schwartz & Drotar (2006) found that survivors with symptoms of PTSS
reported significantly worse Health Related Quality of Life, more depressive
symptoms and mood instability, and lower life satisfaction than a comparison group
without PTSS. Similarly, a comparison of survivors of childhood cancer with and
without a PTSD diagnosis, aged 18-37 years of age and off treatment for
approximately 11 years, indicated that those with PTSD reported higher levels of
anxiety, somatization, obsessive-compulsiveness, depression, paranoid ideation and
interpersonal sensitivity than survivors without PTSD. Survivors in this study were
dichotomized into a PTSD group and non-PTSD group based on formal DSM-IV
diagnostic criteria for PTSD (Meeske, Ruccione, Globe & Stuber, 2001). These
collective findings suggest that survivors with PTSS/PTSD have significant
psychological comorbidity that warrants ongoing evaluation and intervention.
Psychological late effects combined with neurocognitive deficits are often
reflected in higher levels of occupational and employment difficulties as well as
interpersonal problems (e.g. divorce) in survivors (Phillips, Salimi, Lommel, &
9

Andrykowski, 2011; Zeltzer et al., 2009). The impact of a diagnosis of cancer on
interpersonal functioning has been well studied. Beginning at school-age and
adolescence, young cancer patients are reported to experience a higher rate of familial
conflict throughout the course of treatment, characterized by parental distress and
emotional or behavioral disturbances in siblings (Forbasch & Thompson, 2003).
Conflict continues throughout childhood, extending to multiple settings, as adolescent
patients are likely to experience peer conflict and insecurity resulting from factors
such as changes in body image and social isolation secondary to their disease (Forbach
& Thompson, 2003). These difficulties carry through adulthood as survivors report
fear that disease relapse or late effects, such as infertility problems, will impact their
relationships. This often manifests in higher reports of isolation and hostility among
adult survivors, despite an increased stated need for intimacy, when compared to the
general population (Forbach & Thompson, 2003).

Health Behaviors
It is important that cancer survivors practice a healthy lifestyle to reduce
their risk for developing chronic cardiac, pulmonary, and other health conditions that
may result from treatment of their disease. Because of their increased risk for late
effects, even low to moderate levels of negative health behaviors in the survivor
population are alarming and deserve clinical attention (Ford, Barnett, & Werk, 2014).
Studies report variation in prevalence of health behaviors in adult survivors, with rates
of tobacco use ranging from 8-29% and excessive alcohol use ranging from 8-84%
10

(Ford, Barnett & Werk, 2014). Twenty-eight percent of survivors in the CCSS cohort
reported having smoked while 17% were identified as current smokers (Butterfield et
al., 2003). Although prevalence rates for illicit drug use among survivors are relatively
low and typically lower than the general population, recent studies suggest that a
broader classification of drug use would yield higher rates. For example, adolescent
and young adult survivors of childhood cancer demonstrate significantly less
experimentation with cannabis when compared to their healthy peers, but show a
significantly higher rate of abuse of pain medication for non-medical purposes (Bauld,
Toumbourou, Anderson, Coffey & Olsson, 2005). Examination of a young adult
cohort of 117 acute myeloid leukemia (AML) survivors found that 22% of survivors
reported use of tobacco, approximately 25% reported binge drinking, and 10%
reported current marijuana use in the last 30 days (Schultz et al., 2010); however, less
than 10% of survivors reported engaging in cocaine, heroin, or methamphetamine use
during that same period.
When examining nutritional status, studies report that less than 25% of
survivors eat balanced meals and a significant number of survivors do not practice
good dietary habits (Mulhern et al., 1995). Many adolescent and young adult survivors
do not meet the guidelines for fruit and vegetable consumption, or caloric intake
(Demark-Wahnerfried et al., 2005) and their dietary sodium and added sugar intake
are often in excess of recommended levels (Robien, Ness, Kllesges, Baker & Gurney,
2008). Relatedly, less than half of the survivors in the CCSS cohort meet national
guidelines for weekly exercise (Krull et al., 2011). Furthermore, although skin cancer
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is the one of the most common second neoplasms among childhood cancer survivors
(Perkins et al., 2005), only 29% of young adult survivors report practicing sun
protective behaviors to minimize these risks (Zwemer, Mahler, Werchiniak &
Recklitis, 2012).
Numerous factors have been identified to influence the practice of health
behaviors, including, but not limited to demographic factors, treatment variables,
perceptions of risk, self-esteem, neurocognitive impairment, decision making skills,
and emotional distress (Krull et al., 2011). For example, older age at diagnosis has
been associated with more frequent engagement in health risk behaviors such as
physical inactivity and unhealthy diet (Ford, Barnett & Werk, 2014). Similarly, risk
factors for continued smoking among childhood cancer survivors include being older
at diagnosis, being younger than age 14 at time of smoking initiation, not having
graduated high school, and receiving cranial radiation treatment (De Moor et al., 2011,
Miliam, Sussman, Ritt-Olson, 2000). In addition to tobacco use (Hollen & Hobbie,
1993; Miliam, Sussman, Ritt-Olson, 2000), CNS treatment has been positively
associated with the practice of other risky behaviors such as poor diet (Landy et al.,
2013) and inactive lifestyle (Ness et al., 2009) among young survivors. Low selfesteem, social withdrawal, and stress have also been associated with physical
inactivity (Krull et al., 2010), while poor decision-making skills correspond with
higher levels of substance use (Hollen, Hobbie, Donnangelo, Shannon, Erickson,
2007). Neurocognitive impairment has also been found to magnify the survivor’s risk
for not engaging in protective health behaviors (Krull et al., 2011)
12

In addition to the multitude of risk factors described above, PTSS has also
been demonstrated to play a significant role in the health behavioral practices and
associated health outcomes among childhood cancer survivors (Clarke & Eiser, 2007;
Santacrose & Lee, 2006; Schwartz et al., 2012). Specifically, the increase in
depression and anxiety related to PTSS, for example, can increase engagement in
more harmful health behaviors and fewer health promoting behaviors among
childhood cancer survivors, thereby exacerbating the survivor’s late effects. For
example, emotional distress has been found not only to predict smoking, but may also
increase the intensity of tobacco use, and lead to heavier drinking among survivors
(Hollen & Hobbie, 1993; Zeltzer et al., 2009). Additionally, PTSS has been related to
the survivor’s diminished self-efficacy, reduced self-awareness, and poor selfmanagement skills, each of which has been found to interfere with the adoption of
healthy lifestyle practices (Santacrose & Lee, 2006). Lastly, survivors with PTSS who
avoid cancer- related information may not fully understand their health risks, ask the
important questions, or acquire the information necessary to facilitate behavioral
change to improve their health status (Lee, 2006; Tyc, Rai, Lensing & Klosky 2003).
Although considerable attention has been paid to tobacco use and smoking
cessation interventions for survivors, fewer studies have focused on interventions that
address alcohol and drug use, healthy nutrition, or physical activity in this high-risk
group (Ford, Barnett & Werk, 2014). Much of the health behavior research conducted
to date has been limited by small sample sizes, lack of standardized methodologies to
assess health behaviors, failure to account for the influence of psychosocial risk
13

factors such as PTSS, and failure to examine the full range of health behaviors
relevant to the survivor’s health status within a single cohort (Ford, Barnett, Werk,
2014). This is important as studies have demonstrated that survivors who engage in at
least one health-risk behavior, such as smoking, typically engage in other health-risk
behaviors and practice fewer positive health behaviors (Butterfield et al., 2003). For
example, 82.8% of survivors who identified as smokers in one study engaged in at
least one other risk behavior (characterized as lack of proper nutrition or physical
activity, alcohol use, and lack of engagement with healthcare), with 38.5% engaging
in two others, and 24.4% engaging in three unhealthy behaviors in addition to
smoking (Butterfield et al., 2003). These collective findings suggest that targeting
multiple health risk behaviors, while simultaneously reinforcing positive health
behaviors and addressing the psychological morbidity of PTSS, may be necessary to
promote maximal health-related behavioral change among survivors.

Medical Screening and Healthcare Utilization
Appropriately addressing the long-term sequelae of their cancer diagnosis
and treatment requires survivors engage proactively in sustained follow-up risk-based
care and medical screening. The Long-Term Follow-Up Guidelines for Survivors of
Childhood, Adolescent and Young Adult Cancers were established by the Children’s
Oncology group, with the most recent (4th ed.) released in 2013, to promote risk-based
care and provide information on suggested periodic evaluations as well as specific
therapeutic modalities based on the survivor’s prior treatment exposure and personal
14

risk-factors (Oeffinger, Nathan, Kremer, 2008). A study by Krull et al. (2011) found,
however, that survivors do not generally obtain the full recommended medical care
per these guidelines, with only 17% of survivors receiving risk-based care, 58%
receiving general healthcare and 12% receiving no medical treatment. Failure to
receive recommended screenings and treatment may be due, in part, to lack of
awareness regarding risks or understanding of the guidelines by both the survivor and
primary care provider and lack of access to services (Oeffinger et al, 2004).
While socioeconomic factors such as lack of access to health insurance, male
gender, and ethnic minority status influence low rates of healthcare utilization,
cognitive and psychosocial and factors also play a substantial role (Krull et al., 2011;
Oeffinger et al., 2004). Neurocognitive deficits, particularly impaired memory and
executive functioning, have been found to be associated with a lack of adherence to
guidelines for recommended screenings and medical care, while increased pain or
somatic complaints typically predict more involvement in risk-based care (Krull et al.,
2011; Nathan et al, 2008). In an earlier study of childhood cancer survivors, Oeffinger
(2004) reported that survivors treated with high-risk therapies were more likely to
report cancer-related medical visits. However, the likelihood of reporting a cancerrelated medical visit or general physical exam decreased significantly with age and
increasing time from diagnosis (Oeffinger, 2004). This trend is concerning as
healthcare use declined among survivors at a time when the incidence of many late
effects, (i.e. second cancers, cardiovascular disease, osteoporosis) emerged. For
15

optimal risk-based care to occur, it is important survivors learn to effectively
communicate with providers about health care needs, and that healthcare systems find
ways to promote survivor engagement in their personal health care.
The relationship between emotional distress and healthcare utilization has
been less well- established, given the variability in findings across studies.
Specifically, some studies have shown that symptoms of anxiety and depression have
no effect on healthcare use (Krull et al., 2011), while others suggest patients with
greater psychological distress engage in more risk-based care (Nathan et al., 2008).
Rates of health care use may also depend on the survivor’s motivation for seeking out
care. For example, studies have shown that although survivors with increased
emotional distress are often more likely to seek out risk-based care than those who are
psychologically healthy, they expect this care to be supportive (information about
social or health issues) rather than clinically focused (identification and treatment of
medical problems) (Krull et al., 2011; Michel, Greenfield, Absolom, Ross, Davise &
Eiser, 2009; Nathan et al., 2008). Increased compliance with medical follow-up may,
therefore, depends on a broad range of available services being offered within
healthcare systems that match the types of information and/or level of support that
survivors expect and prefer.
Health beliefs, perceptions of health status, and satisfaction with health care
have similarly been shown to influence the survivor’s adherence to recommended
screening, monitoring, and treatment (Cox, Zhu, Hudson, Robison, Oeffinger, 2013;
Ford, Barnett & Werk, 2014; Michael, Greenfield, Absolom, Ross, Davise & Eiser,
16

2009). These studies have demonstrated that survivors who report an increased sense
of vulnerability to health risks and lower self-efficacy for health behavioral change
may be more inclined to seek medical care. However, these studies did not account for
PTSS distinctly, or degree of health problems among their samples of survivors. PTSS
may, in fact, negatively impact engagement with healthcare secondary to the
survivor’s health beliefs and health-related competencies. Although the direct
association between PTSS and healthcare utilization was not assessed in this study,
Schwartz et al (2012) found that survivors with PTSS reported lower perceptions of
health-related competence (i.e. less adaptive beliefs about their health status) as well
as more dissatisfaction with their health care than survivors without PTSS. Increased
PTSS was also reported among survivors with more health problems. It is likely,
therefore, that survivors with PTSS who experience multiple health problems, feel
dissatisfied with their care, and report less adaptive health beliefs, may choose to
disengage from recommended follow-up medical care. The avoidance or arousal
associated with PTSS may further interfere with the survivor’s motivation to adhere to
recommended health care visits (Schwartz et al., 2012). Therefore, interventions that
attempt to modify survivor’s beliefs about health competence and healthcare
satisfaction may not only serve to reduce PTSS in this population, but also to facilitate
better engagement in recommended follow-up medical care.
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Statement of Purpose
In general, research to date established that long-term adult survivors of
childhood cancer report minimal psychological distress but practice unhealthy
lifestyles and report low rates of healthcare utilization (Krull et al., 2011; Nathan et
al., 2008). Moreover, some subgroups of survivors are more vulnerable to
psychological and neurocognitive difficulties and overall poorer quality of life
(Brinkman et al., 2013 [b]; Kazak et al., 2010; Stuber et al., 2010). Although
neurocognitive, psychosocial, health behavior, and healthcare utilization outcomes are
highly interrelated (Krull et al., 2011), few studies have examined multiple outcomes
in a single cohort of survivors. PTSS is prevalent among childhood cancer survivors
and has been found to exacerbate these reported outcomes and late effects (Meeske et
al., 2011; Stuber et al., 2010; Schwartz et al., 2012). Additionally, because there is
considerable overlap in the characteristics of PTSS and measures of psychosocial
distress employed in other studies (Meeske et al., 2001; Santacrose & Lee, 2006),
PTSS has rarely been included as an independent predictor in studies conducted with
survivors. Methodologically, studies of PTSS in childhood cancer survivors have been
plagued by small sample sizes, low response rates, and limited follow-up data (Lee,
2006; Meeske et al., 2001; Schwartz & Drotar, 2005).
This study built on existing literature by examining PTSS as a contributing
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factor in long-term cognitive, emotional, and behavioral health outcomes among
survivors, utilizing a large and well-characterized sample with extensive follow-up
data. This sample allowed for evaluation of demographic and treatment related
variables, as well as outcomes that may arise years after cancer treatment. Unlike prior
studies that typically follow survivors for a limited 5- or 10-year period, this study
examined PTSS and related outcomes in survivors for an extended follow-up period.
The use of long-term follow-up data is critical in this population, as many survivors
begin to experience psychosocial, neurocognitive and other health-related effects later
in life (Brinkman et al., 2013, [b]). The proposed study not only addressed the impact
of PTSS in a large representative sample, but also sought to further add to the
understanding and identification of at-risk survivors who may benefit from additional
forms of long-term follow-up care.

Aims and Hypotheses
Aim 1: To examine the association between posttraumatic stress and concurrent
neurocognitive and emotional health conditions in adult survivors of childhood cancer
Hypothesis 1.1: PTSS will be associated with lower perceived neurocognitive
functioning in all domains
Hypothesis 1.2: PTSS will be associated with higher emotional distress,
perceived cognitive and physical limitations and diminished quality of life
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Aim 2: To examine the association between posttraumatic stress and health behaviors
(i.e. smoking, physical activity) in adult survivors of childhood cancer
Hypothesis 2.1: PTSS will be associated with more negative health behaviors
Hypothesis 2.2: PTSS will be associated with fewer positive health behaviors

Aim 3: To explore the association between posttraumatic stress and healthcare
utilization (i.e. level of primary and risk-based care, presence of medical screening) in
adult survivors of childhood cancer
Hypothesis 3.1: Participants who report clinically significant avoidance will
demonstrate lower healthcare utilization compared to those who report
posttraumatic stress without significant avoidance symptoms
Hypothesis 3.2: Participants who endorse clinically significant hyperarousal will
demonstrate higher healthcare utilization, compared to those who report
posttraumatic stress without this elevation
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Methods
Sample
The Childhood Cancer Survivor Study utilizes a multi-institutional sample
of individuals who have a history of diagnosis and treatment of leukemia, central
nervous system malignancy (excluding meningioma and craniopharyngioma),
Hodgkin Disease, non-Hodgkin lymphoma, neuroblastoma, soft tissue sarcoma,
kidney cancer or bone cancer. These individuals were diagnosed prior to the age of 21,
between the years of 1970 and 1986, who achieved 5-year survival. Baseline data
collection took place between 1994-1998 among survivors from the United States and
Canada (Robison et al., 2008) and follow-up data collection occurred between 20002005 (Robison et al., 2009). Additionally, siblings of these survivors were
administered questionnaires and serve as a normative control group in multiple
measures.
This analysis examined the reports of survivors from the original cohort who
completed the 2003 follow-up survey, completed between the years of 2000-2005. As
the aim of this study was to examine posttraumatic stress as a unique predictor of
outcomes, the portion of survivors who did not show signs of posttraumatic stress
were used as a reference group in the analysis. Siblings were excluded from the
analyses as only 2% of siblings, as compared to 9% of survivors, in this cohort have
demonstrated signs of Posttraumatic Stress Disorder (Stuber et al., 2010).
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Measures
The Childhood Cancer Survivor Study Neurocognitive Questionnaire
(CCSS-NCQ).
Comprised of selected items on the 2003 follow-up survivor and sibling
questionnaires, this is the primary outcome measure of neurocognitive health. This
measure, created by researchers within the CCSS, assesses for executive functioning
deficits commonly seen in those who have undergone radiation and antimetabolic
chemotherapy (Krull et al., 2008). The recent revision was conducted according to the
Behavioral Rating Inventory of executive Functioning, and validated on the survivor
population to accurately identify a variety of mild- moderate impairments. It has been
found to adequately correlate with direct assessments of cognitive functioning and to
adequately capture daily functioning as compared to other parent-report measures
(Krull et al., 2008). This self-report questionnaire contains 25 items on a Likert scale
based on frequency of occurrence over the last 6 months. Responses are scored onto
scales representing four areas of functioning: task efficiency, emotional regulation,
organization, and memory (Krull et al., 2008; Kenzik et al., 2015; Zeltzer et al.,
2009). Totals are then converted to t- scores and interpreted based on normative
sibling data, with impairment defined as falling into the bottom 10th percentile of
siblings (Krull et al., 2008; Kenzik et al., 2015). For this analysis, Neurocognitive
outcomes were coded according to distribution as impaired or not impaired. Analyses
examined perceived functioning in each domain individually.
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The Brief Symptom Inventory- 18 (BSI-18).
The BSI-18 is used as presented on the 2003 follow-up survivor and sibling
questionnaires, this served as a measure of emotional distress. This self-report
inventory contains 18 items on a Likert scale based on severity over the past 7 days.
Scores are placed onto three dimensions: somatization, depression, and anxiety. A
cumulative global distress scale is also calculated (Recklitis et al., 2006). Endorsed
items are totaled, converted to t-scores based on community norms and interpreted
against a clinical cutoff at the top 10th percentile (Recklitis et al., 2006). In addition to
its adequate validity and reliability in the general population, the validity of this
measure has been studied in pediatric cancer survivors. Findings of these studies
indicate the measure has adequate validity, though interpretation should consider
effects of response shift and bias (Recklitis et al, 2006). For this analysis, emotional
distress was coded as a high (above clinical cutoff of 65) and moderate-low (below
clinical cutoff) experience of overall distress as well as on specific scales of
somatization, depression and anxiety.

The Short-Form Survey-36 (SF-36).
The SF-36 is used as presented in the 2003 follow-up survivor/sibling
questionnaires, this self-report questionnaire measures patient-reported physical and
mental health outcomes. It contains 36 items on a Likert scale regarding the presence
of various conditions, as well as their frequency and severity, over the last 4 weeks.
Items endorsed are scored to the following scales: vitality, physical function, bodily
pain, general health perceptions, physical role functioning, emotional role functioning,
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social role functioning, and general mental health (Brandeis University, n.d.).
Weighted scores are calculated for each section and transformed into standard Tscores, though z-scores are also available (Brandeis University, n.d.). Perceived
health-related quality of life will be coded as high- moderate (>60) and low (<40) on
each of these scales. As in the BSI-18, studies showed survivors demonstrate a high
presence of response shift and bias when compared to informant-reports; however,
subsequent analyses indicate this had a non-significant impact on the validity of the
measure.
Health behaviors.
Positive and negative health behaviors are present on questionnaires as they
pertain to smoking status and physical activity. Specific outcomes related to smoking
status included presence and frequency of tobacco use, with frequency measured as
fewer than 10 or at least 10 cigarettes a day and the presence of smoking cessation
attempts. With regards to physical activity, analyses examined the frequency of
moderate/vigorous exercise as compared to national recommendations of at least 3
times per week

Healthcare/medical screening.
Adherence to guidelines with regards to routine medical care and screening
were examined. Primary care visits were examined with regards to low (0 visits),
average (1-6 visits), or frequent (7+ visits) utilization. Frequencies considered average
or frequent were determined by annual reports from the Center for Disease Control
(Center for Disease Control, National Center for Health Statistics, 2009). Participation
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in risk-based care and medical screening were examined similarly with regards to
whether an individual has received this care at least once in the previous year.
Questionnaire information regarding the frequency, type and content of healthcare
visits were used to determine factors associated with use of general and risk-based
healthcare and medical screening.
The Posttraumatic Stress Symptom Scale – Self Report.
The posttraumatic stress measure presented in the 2003 follow-up survivor and
sibling questionnaires served as the predictor variable. This measure was adapted
from the DSM-IV PTSD checklist – civilian edition. This self-report questionnaire
contains 17 items that represent the symptom criteria of PTSD assessed on a Likert
scale of 0-3 based on severity (Foa, Riggs, Dancu & Rothbaum, 1993). A total raw
score is determined by number of items endorsed and compared against a clinical
cutoff score of 13, which suggests high likelihood of PTSD (Foa, Riggs, Dancu &
Rothbaum, 1993). The presence of a likely diagnosis (yes, no) was coded as the
predictor variable. Although it had a greater presence of false-negatives, when
compared to the Posttraumatic Stress-Interview, this measure was found to be valid
when compared to similar inventories (Foa, Riggs, Dancu & Rothnbaum, 1993).
Procedure
Descriptive statistics (including mean, standard deviation and frequencies)
were calculated for survivor demographics, each of the primary outcomes (NCQ, BSI18, SF-36, Tobacco Consumption, Physical Activity, Medical Screening and
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Healthcare Use), the primary predictor (Posttraumatic stress) and all covariates (Table
1). Logistic regression models were constructed between posttraumatic stress and each
of the outcome variables, including adjustment factors as described below (Tables 26). For each model described below, confounding factors were included if their
inclusion modified the association between posttraumatic stress and each outcome of
interest by more than 10%. To account for the high number of covariates and
collinearity between them, analyses were run separately using two models. Model 1
included demographic and treatment characteristics while model 2 included
demographic and disease variables. Model 1 was selected for use in the primary
results, as treatment related variables had a higher predictive power with both PTSS
and related outcomes as compared to disease variables. Odds ratios and relative risk
were calculated.

Aim 1
Multivariable log-binomial regression models were used to examine the
association between posttraumatic stress (yes, no) and emotional health conditions
(BSI-18) and overall health-related quality of life (SF-36). The primary analysis was
based on the BSI Global Distress Score as well as the SF-36 physical and mental
composites, for which relative risk of impairment was calculated (Table 2). Univariate
analyses of variance were also conducted to examine the association between PTSS
and each composite score of these measures (Table 1b) and frequencies were
calculated.
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Multivariable log binomial models were also used to examine the association
between posttraumatic stress (yes, no) and neurocognitive functioning (NCQ-2).
Univariate analyses and frequencies (table 1b) as well as relative risk for impairment
(table 3) were calculated. For each of these, covariates included: treatment type, years
since diagnosis, age at evaluation, second malignant neoplasm, sex, race/ethnicity,
employment status, household income and marital status.

Aim 2
Multinomial logistic regression models examined the impact of posttraumatic
stress (yes, no) on smoking status (never, current, or former). Odds ratios were
calculated and presented in Table 4a. Multivariable log-binomial models were then
used to examine the impact of PTSS on frequency of use (greater or less than 10
cigarettes per day) and cessation attempts. Relative risk of high frequency use were
calculated and presented in Table 4b. Table 4b also displays the relative risk of failure
to meet CDC guidelines for exercise, as calculated in log-binomial regression models.
Univariate analyses and frequencies for each outcome were also calculated (Table 1b).
Covariates included: body mass index, treatment type, years since diagnosis, age at
evaluation, second malignant neoplasm, disease recurrence, sex, race/ethnicity,
employment status, household income, marital status.
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Aim 3
Multinomial logistic regression models were used to examine the impact of
posttraumatic stress on primary healthcare use. Consideration was given to the overall
presence of PTSS (yes, no) (Table 5) and the degree of symptoms in the intrusive,
avoidance, or hyperarousal subscales (per unit increase) (Table 5). Odds ratios were
calculated and presented in Table 5. Univariate analyses and frequency calculations
are also presented in Table 1b. Multivariable log binomial regression models were
then used to examine the impact of posttraumatic stress (yes, no) (Table 6) and
symptom manifestations (per unit increase) (Table 6) on cancer-specific/risk-based
care. Relative risk was calculated and presented in Table 6 while univariate analyses
and frequency calculations are presented in Table 1b. For each of these, covariates
included: body mass index, health insurance, treatment type, years since diagnosis,
age at evaluation, second malignant neoplasm, disease recurrence, sex, race/ethnicity,
employment status, household income, marital status.
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Results
Characteristics of Sample
Table 1a displays the demographic characteristics, as well as diagnosis and
treatment protocols, for study participants with PTSS (n=832) and those without PTSS
(n=5227). Of the total sample of survivors, 13.7% (n=832) met the clinical cutoff
criteria for posttraumatic stress (see Table 1b). There was no significant difference in
mean age at diagnosis or at follow-up between groups with and without PTSS (p>.05).
The proportion of survivors with and without PTSS significantly differed, however.
On the basis of gender (p=.0003) and race (p<.0001) (see Table 1a). An examination
of frequencies showed that among survivors with PTSS, 57.9% identified as being
female and 42.1% identified as male. Additionally, 13.6% of survivors with PTSS
identified as being a member of a racial minority, compared to 8.1% of those without
PTSS (see Table 1a).
Significant group differences (PTSS vs. no PTSS) were also found with regard
to educational and occupational achievement as well as household income (p<.0001).
Significantly more survivors with PTSS identified as unemployed (27.7%), compared
to those without PTSS (8.5%) (p<.0001) (see Table 1a). Similarly, survivors with
PTSS reported a lower household income on average than those with no PTSS. Upon
inspection, 20.5% of survivors with PTSS reported an income below $20,000 per year,
compared to 8.6% of those without PTSS (see Table 1a).
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With regard to cancer diagnosis, Leukemia was the most prevalent diagnostic
group (33.4%) followed by Lymphomas [Hodgkin + non-Hodgkin; (21.7%)],
Sarcomas [bone cancer + soft tissue; (18.5%)], solid tumors [Wilms + neuroblastoma;
(15.8%)] and Central Nervous System tumors (10.6%). There was no significant
difference in diagnosis between survivors with and without PTSS (p>.05, See Table
1b). Disease recurrence, which occurred in 11.2% of the sample, was significantly
more prevalent in those with PTSS (p=0.0005); occurrence of second malignant
neoplasms occurred in 6.5% of the sample and did not significantly differ between
PTSS and non-PTSS groups (p>.05) (see Table 1b). With regards to treatment type,
60.2% of the sample had received cranial radiation, 49.7% had been treated with
Alkylating agents, 38.8% with Anthracyclines, 33.5% with Intrathecal Methotrexate,
and 19.0% with Intravenous Methotrexate. Although there was no significant
difference in chemotherapy type between groups, a history of having received cranial
radiation was more prevalent among those with PTSS than those without (p=0.0047)
(see Table 1b).
Outcomes
Psychosocial outcomes.
Table 2 displays the relative risk, predicted by multivariable log binomial
models, for survivors with PTSS to report clinical distress and impairments in healthrelated quality of life (HRQOL) as compared to those without PTSS, when controlling
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for demographic variables and those related to disease or treatment-type.1 Results
indicated survivors with PTSS were at 8.58 times greater risk to report clinical distress
than those without PTSS (RR=8.58, 95% CI= 7.13-10.32, p<.0001) (see Table 2).
Examination of frequencies showed that 44.4% of survivors with PTSS reported a
clinical degree of overall emotional distress, as compared to 4.4% of those without
PTSS (see Table 1b). There were also a significant association between presence or
absence of PTSS and reported clinical distress across individual domains which
included depression, somatization, and anxiety (p<.0001). Relative to those without
PTSS, a greater proportion of survivors with PTSS reported clinical distress across
these domains (see Table 1b).
With regard to HRQOL, survivors with PTSS were at significantly greater risk
to report impairment in both physical (RR=2.26, 95% CI: 1.96-2.61, p<.0001) and
mental (RR=3.42, 95% CI: 3.05-3.85, p<.0001) domains of functioning (see Table 2).
An examination of frequencies showed that 33.1% of survivors with PTSS, compared
to 10.9% of those without, reported physical impairments in HRQOL while 51.0% of
those with PTSS, and 12.9% of those without, reported mental impairments (see Table
1b). In the domains of physical functioning, significantly more survivors with PTSS
reported low general health perception (p<.0001), impairment resulting from bodily
pain (p<.0001), and low vitality (p<.0001) (see Table 1b). In the domain of mental
1

Across this analysis, separate models were used to account for disease and treatmentrelated covariates. Results did not differ significantly across models. Results in the text are
presented using treatment-related covariates, as they were found to have a greater statistical
significance to PTSS and related outcomes.
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functioning, significantly more survivors with PTSS reported impairment in emotional
(p<.0001) and social (p<.0001) role functioning (see Table 1b)

Neurocognitive outcomes.
Table 3 displays the relative risk, as predicted by multivariable log binomial
models, for survivors with PTSS to report impairment in the various cognitive
domains when controlling for demographic variables, disease, and treatment type.
When compared to survivors without PTSS, survivors with PTSS were at more than 3
times greater risk for perceived impairments in task efficiency (RR= 3.09, 95% CI=
2.72- 3.51, p<.0001) and emotional regulation (RR=3.67, 95% CI= 3.30-4.09,
p<.0001). They were also at more than twice the risk for perceived impairment in
working memory (RR=2.55, CI=2.30-2.83, p<.0001) and organization (RR=2.11,
CI=1.78-2.50, p<.0001) (see Table 3). Examination of frequencies showed that close
to half of survivors with PTSS reported impairments in task efficiency, while more
than half identified impairments in emotional regulation and working memory (see
Table 1b).

Health behaviors.
Frequencies presented in table 1b show that 25.3% of survivors with PTSS
(13.0% of those without PTSS) reported being a current smoker and 17.4% (15.8% of
those without) identified as former smoker. Of those who identified as current
smokers, 71.0% of survivors with PTSS (65.7% of those without) acknowledged
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smoking 10 or more cigarettes a day and 63.9% (59.6% of those without) reported
having attempted to quit smoking at least once. Table 4a displays the likelihood of
survivors with PTSS as compared to those without PTSS to be a current or former
smoker, based on multinomial logistic regressions. As expected, survivors with PTSS
were significantly more likely to be a former (OR=1.44, 95%CI= 1.13-1.83, p=.0027)
or current (OR=2.34, 95%CI=1.88-2.91, p<.0001) smoker, as opposed to having never
smoked, when compared to survivors without PTSS (see Table 4a). The presence or
absence of PTSS was not significantly related to the number of cigarettes smoked or
cessation attempts (p>.05, see Table 4b).
Univariate analyses revealed a significant association between the presence or
absence of PTSS among survivors and body mass index (p=.0009) (see Table 1a).
Approximately 24% of survivors with PTSS were obese in contrast to almost 19% of
those without PTSS. There was also a significant difference in the proportion of
survivors with and without PTSS who met the CDC guidelines for intensity of
exercise (p=.0298). Almost 34% of survivors without PTSS engaged in vigorous
exercise per CDC guidelines compared to 29.4% of those with PTSS (see Table 1b).
Based on multivariable log binomial regression models displayed in tables 4b1 and
4b2, however, PTSS was not significantly related to either meeting or failure to meet
CDC guidelines for exercise overall (p>.05).
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Healthcare utilization.
Table 5 displays the likelihood, as measured by multinomial logistic
regressions, that survivors with PTSS, as compared to those without, engaged in high
or low frequency healthcare utilization relative to average use. As expected, survivors
with PTSS were significantly more likely than those without PTSS to not engage in
general healthcare use, as defined as having had no primary care visits in the past 2years (OR=1.63, 95% CI= 1.32-2.01, p<.0001) (see Table 5) relative to average use,
defined as 1-6 visits. Compared to survivors without PTSS, those with PTSS were also
significantly more likely to have reported a high frequency of medical visits, as
defined as more than seven visits in the past 2-years (OR= 1.89, 95% CI= 1.50-2.39,
p<.0001) (see Table 5) relative to average use. Frequency of primary care visits for the
PTSS and no PTSS groups are presented in Table 1b.
Table 5 also displays the results of multinomial logistic regressions which
examined the relationship between specific symptom manifestations of PTSS on
engagement with primary care. Results indicated that as symptoms of hyperarousal
increased, survivors were significantly more likely to engage in too few (OR=1.04 per
unit increase, 95% CI= 1.01-1.08, p=.0117) or a high frequency of primary care
medical visits (OR= 1.04 per unit increase, 95% CI= 1.00-1.08, p=0.0349) (see Table
5) rather than average use. Increases in intrusive symptoms also corresponded with a
high frequency of primary care medical visits relative to average use (OR=1.08 per
unit increase, 95% CI= 1.02-1.14, p=.0052) (see Table 5).
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Multivariate log binomial regressions, presented in Table 6, predicted the
likelihood of survivors with PTSS to participate in recommended cancer-specific, riskbased care as compared to those without PTSS. Survivors with PTSS were
significantly more likely to have participated in a cancer-specific healthcare visit in
the previous 2-year period (RR=1.31, 95% CI= 1.18-1.46, p<.0001) and complied
with survivorship guidelines to obtain bone density tests (RR=1.41, 95% CI= 1.151.74, p=.0011) (see Table 6). PTSS did not significantly impact engagement in other
recommended screenings, however, which included echocardiograms, colonoscopies,
mammograms (for female survivors) or pap smears (for female survivors) (p>.05; See
Table 6). Frequency of risk-based visits for the PTSS and no PTSS groups are
represented in Table 1b.
Table 6 also displays results of multivariable log binomials which examined
the significance of specific symptom manifestations of PTSS on risk-based care.
Results indicated that as reported symptoms of hyperarousal increased, survivors were
more likely to engage in cancer-specific healthcare visits (RR=1.04 per unit increase,
95% CI= 1.02-1.06, p<.0001) and recommended colonoscopies (RR=1.10 per unit
increase, 95% CI= 1.02-1.19, p=0.0118) (see Table 6). Avoidance was found to have
no significant impact on primary or risk-based care (p>.05, see Table 6).
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Discussion
Impact of Study
Long-term survivors of childhood cancer have been found to experience a
number of late effects which include psychological distress, neurocognitive
impairment, and physical health conditions. Due to these increased risks, promotion of
psychosocial adjustment and healthy lifestyles is particularly important for this
population. A body of research on late effects in childhood cancer survivorship has
sought to both characterize outcomes and identify those who may be at greater risk;
however, relatively few studies have examined multiple outcomes together.
Additionally, few have examined posttraumatic stress as a unique variable, and those
who have are limited by small sample size and lack of extended follow-up data (Lee,
2006; Meeske et al., 2001; Schwartz & Drotar, 2005). Our study examined
posttraumatic stress as a unique predictor of emotional, cognitive, and behavioral
health outcomes among survivors. Of the long-term survivors, 13.7% reported PTSS
at an extended time-period following completion of their cancer treatment. When
compared to survivors without PTSS, those who experienced PTSS were at increased
risk for experiencing emotional distress, poor health-related quality of life, and
neurocognitive impairment. They were also more likely to have smoked, and variably
utilized healthcare.
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The finding that survivors with PTSS in our sample were significantly more
likely to report poor psychosocial outcomes, characterized by higher levels of distress
and lower health-related quality of life than survivors without PTSS, is consistent with
previous research on adult cancer survivors (Meeske, Ruccione, Globe, Stuber, 2001;
Oeffinger, Nathan & Kremer, 2008; Zeltzer et al., 2009). Specifically, survivors were
at significantly greater risk of experiencing clinical distress characterized by
depression, anxiety, and somatization. They were also more likely to report
diminished quality of life resulting from lower perceived mental and physical
functioning that appeared related to bodily pain, vitality, social and emotional role
functioning. These outcomes likely impact the survivors’ interpersonal relationships
as well as affect their sleep, activity level, and overall functioning (Phillips Salimi,
Lommel & Andrykowski, 2011; Zeltzer et al., 2009). Given the relationship between
PTSS and overall distress, ongoing mental health screening and monitoring of
psychological symptoms is critical to minimize the degree of psychosocial late effects
and functional impairment experienced by survivors. Assisting survivors in coping
with the physical sequelae of their disease, including pain, will also be important in
affecting their quality of life.
As predicted, results from this study also found that survivors with PTSS were
significantly more likely than their peers without PTSS to experience perceived
impairments across domains of neurocognitive functioning, which was evident in
emotional regulation, task efficiency, working memory, and organization. While we
controlled for demographic, disease, and treatment-related variables when evaluating
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neurocognitive impairment in our study, it remains difficult to determine if the
emotional distress associated with PTSS contributes to the cognitive impairment
reported or if the cognitive deficits lead to increased clinical distress. Early
identification and remediation of these functional deficits is important, however, given
the association between neurocognitive impairment and poorer adult adaptation,
including occupational and educational functioning (Ellenberg et al., 2009; Krull et
al., 2011). Disruptions in neurocognitive functioning may also affect the survivors’
decision making related to the practice of unhealthy behaviors and compliance with
recommendations for follow-up medical care (Krull et al, 2011). For survivors whose
cognitive skills cannot be significantly improved with traditional cognitive
rehabilitation efforts, vocational rehabilitation, job training, placement services, and
access to programs that promote independent living may also be critically important in
facilitating more positive functional outcomes (Ellenberg et al., 2009).
As it has been well demonstrated that survivors, in general, tend to engage in
fewer positive health behaviors (Krull et al., 2011), and emotional distress is often
associated with their practice of harmful health behaviors (Clarke & Eiser, 2007;
Santacrose & Lee, 2006; Schwartz et al., 2012), the current findings related to tobacco
use and exercise in our sample were not surprising. Consistent with results reported in
other studies, close to 31% of survivors in the study sample were current or former
smokers and survivors with PTSS were more likely to smoke now or in the past when
compared to survivors without PTSS. Similarly, fewer than half of survivors in the
sample reported engaging in regular exercise. Although PTSS did not affect survivors’
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overall adherence to CDC guidelines for exercise, many survivors with PTSS
identified as obese. While exercise is an important factor in maintaining a healthy
weight, it is likely that other factors not assessed in this study (i.e. endocrine
dysfunction, nutritional status) may interact with PTSS to affect weight outcomes.
Nonetheless, providers should monitor and counsel the subgroup of survivors who
have PTSS, are obese, engage in limited physical activity, and use tobacco, which can
increase their risk for chronic health conditions.
While it is important that all survivors sustain long-term follow-up medical
care, our findings showed that survivors with PTSS were significantly more likely to
engage in adequate risk-based care, including cancer-specific health visits and selected
medical screenings, than those without PTSS. However, with respect to primary care,
survivors with PTSS were either significantly more likely to disengage from medical
care (defined as no visits in the prior two years) or to engage in frequent health care
visits (defined as more than 7 visits) as compared to survivors without PTSS.
Examination of unique symptom manifestations of PTSS showed that with increases
in hyperarousal and intrusive symptoms, survivors reported significantly higher rates
of risk-based and primary care utilization. On the basis of our data, it may be that a
certain degree of hyperarousal or intrusive thoughts are protective in that they
facilitate survivor engagement in medical care. For some survivors, however, PTSShyperarousal may interfere with adherence to medical care in the primary care setting.
The relationship between PTSS and health care utilization is obviously complex and
may be attributed to a number of factors, including but not limited to levels of pain
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and number of somatic complaints, health beliefs and perceptions of health status or
competence, expectations and satisfaction with care, knowledge of health risks,
barriers in accessing care, and/or the desire for supportive care (Cox et al., 2013; Ford,
et al., 2014; Michel et al., 2009; Nathan et al., 2008). Understanding what motivates
survivors to engage in medical care and adhere to recommended clinical guidelines is
a promising area of further study.
Based on the findings of our study, posttraumatic stress has been found to
influence psychosocial late effects, neurocognitive functioning, healthcare utilization,
and health behaviors among long-term cancer survivors. Childhood cancer survivors
who present with PTSS and who are clinically distressed, cognitively impaired, and do
not seek follow-up medical care to promote a healthy lifestyle are ideal candidates for
prophylactic intervention. Although we did not directly examine the relationship
between each of the outcomes assessed in this study, it is likely that multiple negative
outcomes are likely to co-occur in some survivors. Therefore, promoting change in
one area of functioning may positively impact other areas of functioning, suggesting
multiple targets for intervention. Targeting posttraumatic stress, a potentially
modifiable factor, is likely to be a central component of the survivor’s long-term
preventative follow-up care, given its association across various domains of
functioning. Identifying multi-component supportive care interventions that prevent
PTSS and help survivors cope with the multiple late effects of treatment is certainly
warranted. Additionally, survivors with PTSS are likely to benefit from
psychoeducation regarding health promotion, particularly as it relates to an increased
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sense of health-related competence. This may be expected to increase survivors’
ability to maintain a healthy lifestyle while seeking needed health care as
recommended by survivorship guidelines.

Limitations of Study & Future Directions
Although this study was able to meet its aims to better characterize late effects
and the impact of posttraumatic stress in the survivor population, consideration should
be given to some methodological limitations. One limitation of this study is that, while
the sample is large, it is described as predominantly Caucasian, such that we may not
be able to adequately examine the long-term health outcomes among minority
survivors. While this is consistent with the general childhood cancer survivor
population (Kazak et al., 2010), the limited number of minority participants restricts
the generalizability of our findings to potential high risk groups (Oeffinger, Nathan &
Kremer, 2008; Robison et al., 2008). Research on the long-term morbidity among
minority survivor populations is certainly warranted to offer race/ethnicity-targeted
recommendations and interventions as well as optimize their follow-up care. In
addition, our study did not account for the potential influence of multiple traumas
experienced by survivors, including childhood experiences and family stressors that
may have been present at the time of illness. Future studies should aim to examine
such factors in order to differentiate the contribution of cancer-specific versus other
trauma on the degree and types of symptoms manifested among survivors.
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Concerns have also been raised about reliance on self-report data in the CCSS
cohort as survivors may under- or over-report their symptoms, in comparing
themselves to other survivors or in an effort to more closely resemble their healthy
peers (Brandeis University, n.d.; Recklitis et al, 2006). It has also been suggested that
survivors who experience traumatic stress may be more avoidant, less willing to
revisit their cancer experience, and therefore less likely to participate in the CSSS
study, resulting in a biased sample of survivors. (Stuber et al., 2010). Consequently,
the observed prevalence of PTSS in survivors may be underestimated in this study.
The use of self-report data to assess perceived neurocognitive functioning may also
represent an additional limitation of the study. Although the CCSS neurocognitive
questionnaire (NCQ) has been validated against self-report and performance based
measures (Krull et al., 2008), future studies may benefit from inclusion of objective,
performance-based data to better understand the nature and degree of survivors’
neurocognitive impairment.. Additionally, although our study made progress in
examining utilization of healthcare among survivors, future studies should better
address reasons for medical visits and account for covariates such as chronic or acute
health conditions, pain severity, and satisfaction with care received. This information
would be most helpful in promoting better engagement of survivors in general and
risk-based follow-up care. Likewise, the scope of this study was limited in the
inclusion of only a few health behaviors. Future research should give more
consideration to healthy lifestyles across a broader behavioral health domain.
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Lastly, this study was limited in its use of cross-sectional data. Because of the
nature of the questionnaire data, directionality and causality cannot be established,
leaving a degree of uncertainty regarding the relationship between predictors and
outcomes. The cross-sectional design of this study also limits our evaluation of the
longitudinal patterns of PTSS and related outcomes following cancer treatment. Future
research should include a longitudinal approach and seek to utilize increased intervals
to better understand directionality of outcomes over time. This will also enable more
precise timing for delivery of targeted interventions for vulnerable cancer survivors at
varying levels of risk.
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Tables
Table 1a
Demographic Frequencies and Univariate Analyses
Variable

Category

w/o PTSS
(n=5227)
M (SD)

with PTSS
(n=832)
M (SD)

Age at diagnosis
Age at baseline

8.7 (5.9)
24.2(7.8)

8.5 (5.7)
23.9 (7.7)

0.1990t
0.2784t

Age at follow-up 2

31.9 (7.6)

31.5 (7.5)

0.1470t

N (%)

N (%)

CNS tumor

610 (10.4)

117 11.8)

Sarcoma (bone cancer + soft tissue

1072 (18.3)

191 (19.2)

Lymphoma (Hodgkin +NHL)
Solid tumor (Wilms+ neuroblastoma)

1285 (22.0)
945 (16.2)

204 (20.5)
133 (13.4)

Leukemia

1937 (33.1)

350 (35.2)

Diagnosis

0.0959

51
Recurrence

0.0005**
Yes
No

625 (10.7)
5224 (89.3)

144 (14.5)
851 (85.5)

Yes
No

372 (6.4)
5477 (93.6)

70 (7.0)
025 (93.0)

Female
Male

3022 (51.7)
2827 (48.3)

576 (57.9)
419 (42.1)

Second Malignant Neoplasm

0.4321

Sex

0.0003**

Race/Ethnicity

<.0001**
White/non-Hispanic
Other
Missing / no response

5353 (91.5)
473 (8.1)

857 (86.1)
135 (13.6)

23 (0.4)

3 (0.3)

Education

<.0001**
High school or less
Some college
College graduate or higher
Missing / no response

1211 (20.7)
1731 (29.6)
2868 (49.0)
39 (0.7)

281 (28.2)
318 (32.0)
390 (39.2)
6 (0.6)

Employment Status

<.0001**
Employed or student
Unemployed
Missing/no response

5242 (89.6)
496 (8.5)
111 (1.9)

750 (75.4)
226 (22.7)
19 (1.9)

Household Income

<.0001**

52

<20,000
20,000 – 39,000
40,000 – 59,000
60,000+
Missing / no response

501 (8.6)
1156 (19.8)
1080 (18.5)
2418 (41.3)
694 (11.9)

204 (20.5)
239 (24.0)
153 (15.4)
271 (27.2)
128 (12.9)

Single
Married or living as married
Missing / no response

2747 (47.0)
3046 (52.1)
56 (1.0)

596 (59.9)
391 (39.3)
8 (0.8)

No
Yes
Missing / no response
.

590 (10.1)
5227 (89.4)
32 (0.5)

155 (15.6)
832 (83.6)
8 (0.8)

Normal / underweight

2865 (49.0)

Marital Status

<.0001**

Health Insurance

Body Mass Index

>.0001**

0.0009**
445 (44.7)

Anthracyclines in 1st 5 years

Alkylating agents 1st 5-yr

Methotrexate IV 1st 5-yr
Methotrexate IT 1st 5-yr

0.4486
Yes
No
Missing
Missing
No
Yes
Missing
0: No
1: Yes
Missing
0: No
1: Yes

2113 (36.1)
3364 (57.5)
372 (6.4)
378 (6.5)
2763 (47.2)
2708 (46.3)
432 (7.4)
4393 (75.1)
1024 (17.5)
523 (8.9)
3555 (60.8)
1771 (30.3)

369 (37.1)
556 (55.9)
70 (7.0)
75 (7.5)
450 (45.2)
470 (47.2)
91 (9.1)
724 (72.8)
180 (18.1)
117 (11.8)
569 (57.2)
309 (31.1)

0.3723

0.4749
0.2588

53
M (SD)

M (SD)

289.4(150.2)

296.6(148.4)

0.4220t

Alkylating agents dose >0

9024.8(9109.2)

9096.8(8389.6)

0.8761t

Methotrexate IV dose >0

3529.1(81670.8)

35969.1(73401.1)

0.9169t

Methotrexate IT Dose >0
Cranial Radiation (dose
>0) (4119)

159.7 (168.5)
1407.5 (1716.5)

157.5 (104.3)
1628.0 (1826.1)

0.7635t
0.0047t

1689 (28.9)
1103 (18.9)
192 (3.3)

273 (27.4)
236 (23.7)
41 (4.1)

Anthracycline dose >0

Overweight
Obese
Missing / no response

Table 1b
Frequencies and Univariate Analyses for Predictor and Outcome Variables
Variable

Category

w/o PTSS
(n=5227)
N (%)

Posttraumatic Stress
Brief Symptom Inventory (BSI)
Global Distress

5227(86.3)

w/PTSS
(n=832)
N (%)
832 (13.7)
<.0001**

Not elevated (<65)
Elevated at 65+
Insufficient Responses

5569(95.2)
258 (4.4)

549 (55.2)
442 (44.4)

22 (0.4)

4 (0.4)

Somatization

<.0001**

54

Not elevated (<65)
Elevated at 65+

5298(90.6)
529 (9.0)

560 (56.3)
431 (43.3)

Insufficient Responses

22 (0.4)

4 (0.4)

Not elevated (<65)
Elevated at 65+
Insufficient Responses

5466(93.5)
363 (6.2)
20 (0.3)

545 (54.8)
447 (44.9)
3 (0.3)

Depression

<.0001**

Anxiety

<.0001**
Not elevated (<65)
Elevated at 65+
Insufficient Responses

5621(96.1)
207 (3.5)
20 (0.3)

671 (67.4)
321 (32.3)
3 ().3)

HRQOL -Short-Form 36
Physical Composite

<.0001**
Not elevated (<60)
Elevated at 60+

Mental Composite

p-value

5148(88.0)
638 (10.9)

649 (65.2)
329 (33.1)
<.0001**

Not Elevated (<60)

5030 (86.0)

471 (47.3)

Elevated at 60+
Insufficient Responses

756 (12.9)
63 (1.1)

507 (51.0)
17 (1.7)

Not elevated (<60)
Elevated at 60+
Insufficient Responses

4683 (80.1)
1152 (19.7)
14 (0.2)

436 (43.8)
554 (55.7)
5 (0.5)

Not elevated (<60)
Elevated at 60+
Insufficient Responses

4956 (84.7)
873 (14.9)
20 (0.3)

551 (55.4)
439 (44.1)
5 (0.5)

Not elevated (<60)
Elevated at 60+
Insufficient Responses

4745 (81.1)
1084 (18.5)
20 (0.3)

466 (46.8)
523 (52.6)
6 (0.6)

Not elevated (<60)
Elevated at 60+
Insufficient Responses

5033 (86.0)
781 (13.4)
35 (0.6)

498 (50.1)
489 (49.1)
8 (0.8)

Not elevated (<60)
Elevated at 60+
Insufficient Responses

5323(91.0)
517 (8.8)
9 (0.2)

548 (55.1)
445 (44.7)
2 (0.2)

Vitality

<.0001**

Bodily pain

<.0001**

General Health Perception

<.0001**

55

Emotional Role Function

<.0001**

Social Role Function

<.0001**

Smoking Status

<.0001**
Never smoker
Former smoker
Current smoker
Missing / no response

4156(71.1)
927 (15.8)
758 (13.0)
8 (0.1)

568 (57.1)
173 (17.4)
252 (25.3)
2 (0.2)

Frequency of use

0.1216

__

<9 cigarettes per day
10+ cigarettes per day

253 (33.4)
498 (65.7)

71 (28.2)
179 (71.0)

Missing / no response

8 (0.1)

2 (0.2)

273 (36.0)
452 (59.6)

82 (32.5)
161 (63.9)

33 (4.4)

9 (3.6)

Cessation attempts

0.2737
0 attempt
1+ attempt
Missing / no response

Exercise (overall)

0.0975
Not meeting criteria
CDC by moderate
CDC by vigorous
Meeting overall criteria
Missing/no response

3245 (55.5)
566 (9.7)
1969(33.7)
2535(43.3)
69 (1.2)

578 (58.1)
109 (11.0)
293 (29.4)
402 (40.4)
15 (1.5)

0 visits

1974(33.7)

397 (39.9)

1-6 visits

2667(45.6)

311 (31.3)

7+ visits
Missing / no response

1178(20.1)
30 (0.5)

281 (28.2)
6 (0.6)

Primary care/2yr

<.0001**
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Cancer-specific visit

<.0001**
Not in past 2 yr
Yes in past 2 yr
Missing / no response

4097(70.0)
1702(29.1)
50 (0.9)

561 (56.4)
420 (42.2)
14 (1.4)

Echocardiogram

0.0360*
Not following guidelines
Following guidelines
Missing / no response

916 (15.7)
412 (7.0)
148 (2.5)

127 (12.8)
79 (7.9)
36 (3.6)

Colonoscopy

0.2317
Not following
Following guidelines

636 (10.9)
107 (1.8)

106 (10.7)
24 (2.40

Bone Density test

<.0001**
Not following

1864(31.9)

291 (29.2)

Following guidelines

507 (8.7)

135 (13.6)

Missing / no response

283 (4.8)

62 (6.2)

Mammogram (for women)

0.5196
Not following

524 (17.3)

99 (17.2)

Following guidelines

356 (11.8)

60 (10.4)

Missing / no response

11 (0.4)

5 (0.9)

Pap smear (women)

0.0047**
Not following

633 (20.9)

151 (26.2)

Following guidelines

2172 (71.9)

384 (66.7)

Missing / no response

32 (1.1)

9 (1.6)

Neurocognitive Questionnaire
Task efficiency

<.0001**
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Not impaired

5058(86.5)

513 (51.6)

Impaired

753 (12.9)

471 (47.3)

Insufficient Responses

38 (0.6)

11 (1.1)

Emotional regulation

<.0001**
Not impaired

4946 (84.6)

411 (41.3)

Impaired

867 (14.8)

570 (57.3)

Insufficient Responses

36 (0.6)

14 (1.4)

Organization

<.0001**
Not impaired

5219 (89.2)

732 (73.6)

Impaired

595 (10.2)

252 (25.3)

Insufficient Responses

35 (0.6)

11 (1.1)

Working memory

<.0001**
Not impaired

4689(80.2)

449 (45.1)

Impaired

1123(19.2)

535 (53.8)

Insufficient Responses

37 (0.6)

11 (1.1)

Table 2
Relative Risk for High Emotional Distress and Impairments in Health-Related Quality of Life Based on Presence of PTSS1
Variable

BSI2

Category

SF-36
Global Distress Index
(n=4798)3

PTSS

No
Yes
.

RR

95% CI

1.00
8.58

.
7.13-10.32

p.
<.0001*

RR
1.00
2.26

4

Physical Composite
(n=4757)3
95% CI
.
1.96-2.61

p.
<.0001*

.

58
*p<.01
Brief Symptom Inventory
3
number of participants who completed corresponding measure on questionnaire
4
Short-Form 36

2

SF-36
Mental Composite
(n=4757)3
RR
1.00
3.42

95% CI

3.05-3.85

p-value

<.0001*

Table 3
Relative Risk for Neurocognitive Impairment Based on Presence of PTSS1
Variable Category

Task
Efficiency
(n=4779)4
RR

PTSS

No

1.00

Yes

3.09

95% CI
.

Emotional
Regulation
- (n- (n=4781)5
p.

2.72- 3.51 <.0001*

RR 95% CI
1.00

.

3.67 3.30- 4.09

---Working
M Memory
(n=4781)5
p-

RR

.

1.00

<.0001*

2.55

95% CI
.
2.30- 2.8

Organization
(n=4781)5

p.
<.0001*

59
*p<.01
4
number of participants who completed corresponding portion of neurocognitive questionnaire

RR

95% CI

p-

1.00

.

.

2.11

1.78- 2.50 <.0001*

Table 4a
Odds Ratio for Effect of PTSS on Smoking Status1

Variable

Category

Category
OR

PTSS

Smoking status
(n=4690)5
95% CI

p-

No

Never Smoker

1.00

Yes

Former smoker

1.44

1.13- 1.83

0.0027*

Yes

Current smoker

2.34

1.88- 2.91

<.0001*

60
*p<.01
5
Number provided an answer regarding smoking status on the questionnaire

.

.

Table 4b
Relative Risk of Not Meeting CDC Guidelines for Exercise and of High Frequency Tobacco Use, Based on Presence of PTSS

Variable Category

Exercise (CDC criteria)
(n=4656)6
RR

PTSS

No
Yes

95% CI

1.00
0.99

.
0.90-1.08

Frequency of use for current smokers Previous cessation for current smokers
(n=667)7
(n=646)7

p-

RR
.

1.00

0.7520

1.06

61

*p<.05
6
answered corresponding question(s) on questionnaire

95% CI
.
0.95-1.18

p.

RR
1.00 .

0.2836

1.04

95% CI

p.

0.92-1.17

0.5618

Table 5
Effect of PTSS and its Individual Symptom Manifestations on Frequency of Primary Care Engagement
Variable

Category
Category

PTSS
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Hyperarousal
Hyperarousal
Avoidant
Avoidant
Intrusive
Intrusive

95% CI
.

p.

No

1-6 visit

Yes

0 visits

1.63

1.32- 2.01

<.0001*

Yes

7+ visits

1.89

1.50- 2.39

<.0001*

Per unit
Per unit
Per unit
Per unit
Per unit
Per unit

0 visits
7+ visits
0 visits
7+visits
0 visits
7+ visits

1.04
1.04
1.01
1.01
1.04
1.08

1.01-1.08
1.00-1.08
0.98-1.04
0.98-1.05
0.99-1.09
1.02-1.14

0.0117*
0.0349
0.4735
0.4965
0.1702
0.0052

*p<.01
7

primary care physician
visits (n=4659)7
OR
1.00

completed corresponding portion of questionnaire

Table 6
Effect of PTSS and its Individual Symptom Manifestations on Frequency of Primary Care Engagement

PTSS
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Cancer-specific health Echocardiogram
(n=46468)
(n=11649)
RR 95% p-value RR 95%
pvalue
CI
CI

Colonoscopy
(n=68310)
RR 95%
pvalue
CI

Bone Density
(n=195011)
RR 95% p-value
CI

Mammogram
(n=74812)
RR 95%
pvalue
CI

No

1.00

.

.

1.00

.

.

1.00

.

.

1.00

.

.

1.00

.

.

1.00

.

.

Yes

1.31

1.181.46

<.0001*

1.19

0.941.50

.1442

1.24

0.762.03

.3869

1.41

1.151.74

.0011*

0.94

0.721.22

.6193

0.98

0.911.04

.4613

1.0
4

1.02
1.06
0.98
1.01
1.02
1.07

<.0001
*

1.01

0.640
3

1.1
0

1.0
3

1.1
0

1.0

.2021

1.1
0

.8140

1.1
0

.713
2

1.01

.0014*

1.07

.0048
*

1.0
1

.9227

1.0
3

.2947

1.1
0

.998
6

1.00

0.99
1.01
0.99
1.01
0.98
1.02

.447
6

0.9
5

0.96
1.04
0.97
1.05
0.94
1.06

.818
7

.5667

1.00
1.07
0.96
1.03
0.98
1.08

.0846

0.99

1.02
1.19
0.88
1.03
0.89
1.14

.0118
*

.5978

0.97
1.05
0.95
1.03
1.02
1.12

Hyper.
/ unit
Avoidance
/ unit
Intrusive
/ unit

1.0
0
1.0
4

p<.01
8
number of participants who completed portion of questionnaire
9-13
number of participants who were eligible for screening and completed related portion of questionnaire

RR

Pap smear visit
(n=231813)
p95%
value
CI

.940
9
.997
9

